Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€309.00
15.09.22
15.09.22
€550.00
15.09.23
15.09.23
74.76%
16.09.23
16.09.23
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€551.50
07.09.22
07.09.22
€700.00
31.12.25
31.12.25
-10.44%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€69.37
07.09.22
07.09.22
€100.00
31.12.25
31.12.25
-12.07%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€285.85
07.09.22
07.09.22
€400.00
31.12.25
31.12.25
10.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€312.95
07.09.22
07.09.22
€450.00
31.12.25
31.12.25
24.24%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€90.50
24.08.22
24.08.22
€120.00
24.08.23
24.08.23
17.79%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€64.74
22.08.22
22.08.22
€80.00
22.08.23
22.08.23
8.80%
23.08.23
23.08.23
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Zoetis Inc. A
Start price
Target price
Perf. (%)
€176.92
03.08.22
03.08.22
€190.00
03.08.23
03.08.23
-6.34%
03.08.23
03.08.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.24
31.07.22
31.07.22
€50.00
31.07.23
31.07.23
-31.05%
22.05.23
22.05.23
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Medtronic plc
Start price
Target price
Perf. (%)
€91.39
27.07.22
27.07.22
€100.00
27.07.23
27.07.23
-11.48%
28.07.23
28.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€49.74
20.07.22
20.07.22
€55.00
20.07.23
20.07.23
-33.55%
21.07.23
21.07.23
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Johnson & Johnson
Start price
Target price
Perf. (%)
€175.60
13.07.22
13.07.22
€168.00
13.07.23
13.07.23
-19.13%
13.07.23
13.07.23
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€235.25
13.07.22
13.07.22
€239.00
13.07.23
13.07.23
-1.59%
13.07.23
13.07.23
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€613.40
10.07.22
10.07.22
€999.00
10.07.23
10.07.23
-6.06%
23.07.22
23.07.22
Could be very worthwhile Investment >20% year
AbbVie Inc.
Start price
Target price
Perf. (%)
€137.98
05.06.22
05.06.22
€155.00
05.06.23
05.06.23
-7.09%
06.06.23
06.06.23
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€471.15
17.05.22
17.05.22
-
17.05.23
17.05.23
-6.19%
17.05.23
17.05.23
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€72.88
16.05.22
16.05.22
-
16.05.23
16.05.23
-2.92%
27.05.22
27.05.22
Probably not worthwhile Investment
Business model of the past or high risk
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Johnson & Johnson
Start price
Target price
Perf. (%)
€174.42
27.04.22
27.04.22
€190.00
27.04.23
27.04.23
-15.38%
27.04.23
27.04.23
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.65
07.04.22
07.04.22
€56.00
07.04.23
07.04.23
-24.58%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation